These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 11869618)

  • 1. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    van der Heijden JF; Hutten BA; Büller HR; Prins MH
    Cochrane Database Syst Rev; 2002; (1):CD002001. PubMed ID: 11869618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    van Der Heijden JF ; Hutten BA; Büller HR; Prins MH
    Cochrane Database Syst Rev; 2000; (4):CD002001. PubMed ID: 11034739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    Andras A; Sala Tenna A; Crawford F
    Cochrane Database Syst Rev; 2012 Oct; 10():CD002001. PubMed ID: 23076894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    Andras A; Sala Tenna A; Stewart M
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.
    Hutten BA; Prins MH
    Cochrane Database Syst Rev; 2000; (3):CD001367. PubMed ID: 10908494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
    van Den Belt AG; Prins MH; Lensing AW; Castro AA; Clark OA; Atallah AN; Burihan E
    Cochrane Database Syst Rev; 2000; (2):CD001100. PubMed ID: 10796593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.
    Hutten BA; Prins MH
    Cochrane Database Syst Rev; 2006 Jan; (1):CD001367. PubMed ID: 16437432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.
    Quinlan DJ; McQuillan A; Eikelboom JW
    Ann Intern Med; 2004 Feb; 140(3):175-83. PubMed ID: 14757615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for people with cancer and central venous catheters.
    Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.
    Gould MK; Dembitzer AD; Doyle RL; Hastie TJ; Garber AM
    Ann Intern Med; 1999 May; 130(10):800-9. PubMed ID: 10366369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.
    Akl EA; Karmath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook D; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006468. PubMed ID: 17636845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants.
    Iorio A; Guercini F; Pini M
    J Thromb Haemost; 2003 Sep; 1(9):1906-13. PubMed ID: 12941030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement.
    Salazar CA; Malaga G; Malasquez G
    Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD005981. PubMed ID: 20393944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of low- molecular- weight- heparin versus vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: a systematic review of randomized controlled trials.
    Louzada ML; Majeed H; Wells PS
    Thromb Res; 2009 Apr; 123(6):837-44. PubMed ID: 18977517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Barba M; Rohilla S; Terrenato I; Sperati F; Muti P; Schünemann HJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006650. PubMed ID: 18425959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation for patients with cancer and central venous catheters.
    Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006468. PubMed ID: 21491394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation for patients with cancer and central venous catheters.
    Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006468. PubMed ID: 21328283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
    van Dongen CJ; van den Belt AG; Prins MH; Lensing AW
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001100. PubMed ID: 15495007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Vardi M; Zittan E; Bitterman H
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006771. PubMed ID: 19821386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Labedi N; Barba M; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006650. PubMed ID: 21678361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.